GO2KA1

GO2KA1


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
diabetes, raw materials, blood glucose management, clinical proven
Category
Health Care Supplement

KunpoongbioCo., Ltd.

Recent Visit
Nov 13, 2024
Country / Year Established
South Korea South Korea /
Business type
Others
Verified Certificate

16

Product name GO2KA1 Certification -
Category Health Care Supplement Ingredients -
Keyword diabetes , raw materials , blood glucose management , clinical proven Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock -
Supply type - HS code -

Product Information

KUNPOONG BIO CO., LTD Introduces New Clinically Proven Blood Sugar Nutraceutical

 

GO2KA1™ is a breakthrough, naturally derived, patent-pending nutraceutical designed to define the benchmark for the glucose management category. Containing low molecular weight chitosan oligosaccharide bioactives derived from crab shells, clinically proven GO2KA1™ helps promotes both long-term blood sugar maintenance as well as short-term post-prandial responses via multiple mechanisms of action.

 

GO2KA1’s efficacy, high bioavailability, and safety have been demonstrated in short-term and long-term, randomized, double-blind, placebo-controlled human clinical trials involving healthy subjects, as well as pre-clinical research. 

 

The first smaller clinical trial, evaluated the effect of GO2KA1 on carbohydrate hydrolysis enzymes and showed that the postprandial blood glucose levels after meal are reduced. This is the first mechanism of action. The second larger clinical trial, evaluated the effect of GO2KA1 on insulin sensitivity, since we administrated GO2KA1 for 3 months and we evaluated what are the postprandial blood glucose levels after OGTT. This is the second mechanism of action.

GO2KA1 has a dual mechanism of action: 1) Inhibition of carbohydrate hydrolysis enzymes that results in management of glucose uptake from the small intestine after meal and 2) enhancement of insulin sensitivity for better utilization of glucose within fat and muscle cells.

 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

KunpoongbioCo., Ltd.

Country / Year Established
South Korea South Korea /
Recent Visit
Nov 13, 2024
Business type
Others

16

President
ChenGum Oh
Address
-
Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My TK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more